4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0001209191-23-006990
Chief Scientific Officer acquired 81,006 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Leen Ann M. · Chief Scientific Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-01-18 | Grant or award : show line 1 in the form | +23,256 | 51,256 | D |
| 2022-07-01 | Grant or award : show line 2 in the form | +14,000 | 65,256 | D |
| 2023-02-02 | Grant or award : show line 3 in the form | +43,750 | 124,006 | D |
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-01-18 | Grant or award : show line 4 in the form Stock Option (Right to Buy) | +56,744 | 366,344 | D |
| 2022-07-01 | Grant or award : show line 5 in the form Stock Option (Right to Buy) | +26,000 | 392,344 | D |
| 2023-02-02 | Grant or award : show line 6 in the form Stock Option (Right to Buy) | +81,250 | 473,594 | D |
Loading xslF345X03/doc4.xml…